Lawmakers in Oregon are considering a bill for the second time that would impose stricter regulations on corporate ownership of physicians' offices and medical clinics, The Oregonian/OregonLive reported March 5. 

Here are three recent studies, policy updates and market trends that could affect healthcare private equity groups in the near future:  

Private equity ownership of medical groups likely connects to higher rates of physician turnover according to a study published in JAMA Feb. 14. 

The California Legislature has introduced a bill that would increase scrutiny over private equity transactions in healthcare after Gov. Gavin Newsom vetoed a similar bill last year, according to a Feb. 17 article from the Polsinelli law firm published by JD Supra. 

Simon Schwartz, COO of Englewood-based Strategic Resources Group Colorado, joined Becker's to discuss the evolving role of private equity in healthcare, particularly its necessity for many physicians navigating an increasingly expensive environment.

Bankers and private equity advisors are shifting their focus toward physician practice deals in 2025, opening up key legal and business considerations for physicians as they prepare for potential transactions, law firm Foley & Lardner wrote in a Feb. 10 article published in JD Supra. 

After several years of slowing deal activity, bankers and private equity firms are again eyeing physician practices for deals in 2025. 

Healthcare private equity firms have been at the center of controversy in recent months after a year of notable Chapter 11 filings and increased regulatory scrutiny from a number of states. 

At least six state legislatures have introduced bills in the last two weeks to increase regulatory scrutiny of private equity mergers and acquisitions in the healthcare space. 

While private equity activity in healthcare has been high over the last several years, a more recent rise in bankruptcies and defaults points to a possible rough patch for healthcare PE investments. 

Here are what three ASC leaders outlined as pros and cons of private equity in the ASC industry:

On Jan. 8, Gov. Maura Healey signed a bill into law that will increase scrutiny of healthcare transactions, according to a Jan. 10 report from The National Law Review.

Massachusetts Gov. Maura Healey is again eyeing legislation that would increase oversight of private equity activity in healthcare, Mass Live reported Jan. 2. 

While many ASCs remain independent, private equity has become an established force in the industry, with notable movements in 2024.

California and Massachusetts both attempted to pass legislation that would tighten regulations around private equity transactions in healthcare, but it is unlikely that either state will see the proposed bills become law before the end of 2024, Bloomberg reported Dec. 22. 

Here are five recent private equity deals, finalized or rumored, that ASCs are eyeing:

Private equity backed healthcare clinic Forward plans to close its doors just a year after raising $100 million in a Series E funding round, according to a Nov. 13 report from Business Insider.

Private equity activity in healthcare has increased over the last decade, and some states have passed or have pending legislation that could increase scrutiny over private equity deals in healthcare.

Ker Leader Medical, a newly established ASC development company, is committed to preserving the autonomy of physicians and ASC leadership. 

Kathleen Fisher Enyeart, counsel at Lathrop GPM, recently spoke with JDSupra to highlight key healthcare regulatory trends that she expects will shape the landscape for ASCs and physicians in the coming year.